Platinum Investment Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,872
| Closed | -$2.39M | – | 156 |
|
|
2021
Q3 | $2.39M | Hold |
13,872
| – | – | 0.07% | 93 |
|
|
2021
Q2 | $1.74M | Hold |
13,872
| – | – | 0.04% | 98 |
|
|
2021
Q1 | $1.88M | Hold |
13,872
| – | – | 0.04% | 89 |
|
|
2020
Q4 | $1.77M | Hold |
13,872
| – | – | 0.04% | 97 |
|
|
2020
Q3 | $1.56M | Sell |
13,872
-5,928
| -30% | -$590K | 0.04% | 89 |
|
|
2020
Q2 | $1.89M | Sell |
19,800
-3,087
| -13% | -$298K | 0.04% | 89 |
|
|
2020
Q1 | $2.06M | Sell |
22,887
-28,602
| -56% | -$2.22M | 0.05% | 70 |
|
|
2019
Q4 | $2.73M | Hold |
51,489
| – | – | 0.05% | 59 |
|
|
2019
Q3 | $2.03M | Hold |
51,489
| – | – | 0.05% | 60 |
|
|
2019
Q2 | $2.12M | Hold |
51,489
| – | – | 0.05% | 54 |
|
|
2019
Q1 | $2.4M | Hold |
51,489
| – | – | 0.06% | 59 |
|
|
2018
Q4 | $2.24M | Hold |
51,489
| – | – | 0.08% | 43 |
|
|
2018
Q3 | $2.95M | Sell |
51,489
-7,011
| -12% | -$345K | 0.08% | 41 |
|
|
2018
Q2 | $2.84M | Hold |
58,500
| – | – | 0.07% | 42 |
|
|
2018
Q1 | $2.29M | Hold |
58,500
| – | – | 0.06% | 47 |
|
|
2017
Q4 | $2.48M | Hold |
58,500
| – | – | 0.07% | 46 |
|
|
2017
Q3 | $2.18M | Sell |
58,500
-10,500
| -15% | -$364K | 0.06% | 48 |
|
|
2017
Q2 | $2.1M | Buy |
69,000
+25,400
| +58% | +$736K | 0.06% | 45 |
|
|
2017
Q1 | $1.15M | Buy |
+43,600
| New | +$1.15M | 0.03% | 62 |
|
Platinum Investment Management's XLRN Position: Q4 2021 in Review
Platinum Investment Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 13,872 shares — an estimated $2.39M sold.
Platinum Investment Management first reported a position in XLRN in Q1 2017 and held it in 19 quarters. The position peaked at $2.95M in Q3 2018. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Platinum Investment Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Platinum Investment Management sold 13,872 Acceleron Pharma shares in Q4 2021, an estimated $2.39M.
- Platinum Investment Management first reported a position in Acceleron Pharma in Q1 2017 and held it in 19 quarters.
- Platinum Investment Management's Acceleron Pharma position peaked at $2.95M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Platinum Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.